Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease-Reference-Cited by-同舟云学术

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Published:2016-11-07 Issue:1 Volume:45 Page:139-149
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Schwabl P.¹²,Mandorfer M.¹²,Steiner S.¹²,Scheiner B.¹²,Chromy D.¹²,Herac M.³,Bucsics T.¹²^ORCID,Hayden H.¹,Grabmeier-Pfistershammer K.²⁴,Ferlitsch A.¹,Oberhuber G.³,Trauner M.¹,Peck-Radosavljevic M.¹²,Reiberger T.¹²

Affiliation:

1. Division of Gastroenterology and Hepatology; Department of Internal Medicine III; Medical University of Vienna; Vienna Austria

2. Vienna HIV & Liver Study Group; Medical University of Vienna; Vienna Austria

3. Clinical Institute of Pathology; Medical University of Vienna; Vienna Austria

4. Division of Immunology, Allergy and Infectious Diseases; Department of Dermatology; Medical University of Vienna; Vienna Austria

Funder

Medical Scientific Fund of the Major of the City of Vienna

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13844/fullpdf

Reference54 articles.

1. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

2. EASL recommendations on treatment of hepatitis C 2015;European Association for Study of the Liver;J Hepatol,2015

3. Epidemiology of viral hepatitis and HIV co-infection;Alter;J Hepatol,2006

4. The burden of liver disease in human immunodeficiency virus-infected patients;Puoti;Semin Liver Dis,2012

5. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis;Pineda;Hepatology,2005

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices;Pharmacological Reports;2024-08-20

2. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

3. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis;Hepatology Research;2024-06-05

4. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices;2024-05-13

5. The fade-out of HCV coinfection in people who live with HIV;Hepatology;2024-05-01